• Pfizer's $11.6B wager; TIGIT implosion; An unusual pharma-biotech pact; Inside a16z's vision to reshape biotech; and more

    14 days ago - By San Diego Biotechnology

    Welcome back to Endpoints Weekly, your review of the week's top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up...
    Read more ...